succinylcholine has been researched along with Genetic Predisposition in 9 studies
Succinylcholine: A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for.
succinylcholine : A quaternary ammonium ion that is the bis-choline ester of succinic acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe a child who developed a malignant hyperthermia-like syndrome after exposure to succinylcholine and halothane." | 3.75 | Malignant hyperthermia-like syndrome and carnitine palmitoyltransferase II deficiency with heterozygous R503C mutation. ( Hogan, KJ; Vladutiu, GD, 2009) |
| "In this article the pathophysiology of malignant hyperthermia, its signs, symptoms and treatment as well as safe anesthetic agents for individuals susceptible to malignant hyperthermia are discussed." | 2.42 | [Malignant hyperthermia]. ( Glahn, KP, 2003) |
| " The successful treatment is based on an early diagnosis, immediately interruption of triggering agents, intravenous administration of Dantrolene in sufficient dosage and starting of adequate symptomatic treatment." | 2.41 | [Malignant hyperthermia]. ( Ben Ammar, MS; Bouhajja, B; Haddad, F, 2002) |
| "Sporadic clinical episodes of malignant hyperthermia (MH) that develop during general anaesthesia (GA) have been reported in Singapore." | 1.46 | Malignant Hyperthermia and Ryanodine Receptor Type 1 Gene (RyR1) Mutation in a Family in Singapore. ( Lai, PS; Lee, DW; Lee, TL; Li, DW; Yong, RY, 2017) |
| "A positive DNA test indicates malignant hyperthermia susceptibility with "causative" mutations but discordance requires that negative DNA tests are confirmed with in vitro contracture test." | 1.31 | Suspected malignant hyperthermia reactions in New Zealand. ( Couchman, K; Langton, EE; Pollock, AN; Stowell, KM; Waddington, M, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Baye, JF | 1 |
| Petry, NJ | 1 |
| Jacobson, SL | 1 |
| Moore, MM | 1 |
| Tucker, B | 1 |
| Shaaban, S | 1 |
| Massmann, AK | 1 |
| Clark, NM | 1 |
| Schultz, AJ | 1 |
| Li, DW | 1 |
| Lai, PS | 1 |
| Lee, DW | 1 |
| Yong, RY | 1 |
| Lee, TL | 1 |
| Hogan, KJ | 1 |
| Vladutiu, GD | 1 |
| Pollock, AN | 1 |
| Langton, EE | 1 |
| Couchman, K | 1 |
| Stowell, KM | 1 |
| Waddington, M | 1 |
| Bouhajja, B | 1 |
| Haddad, F | 1 |
| Ben Ammar, MS | 1 |
| Glahn, KP | 1 |
| Rosenberg, H | 1 |
| Davis, M | 1 |
| James, D | 1 |
| Pollock, N | 1 |
| Stowell, K | 1 |
| Antel, JP | 1 |
| Arnason, BG | 1 |
| Cosgrove, SB | 1 |
| Eisele, PH | 1 |
| Martucci, RW | 1 |
| Gronert, GA | 1 |
4 reviews available for succinylcholine and Genetic Predisposition
| Article | Year |
|---|---|
[Malignant hyperthermia].
Topics: Anesthesia, General; Dantrolene; Diagnosis, Differential; Genetic Predisposition to Disease; Humans; | 2002 |
[Malignant hyperthermia].
Topics: Anesthetics, Inhalation; Dantrolene; Diagnosis, Differential; Genetic Predisposition to Disease; Hum | 2003 |
Malignant hyperthermia.
Topics: Adolescent; Adult; Aged; Animals; Child; Child, Preschool; Diagnosis, Differential; Female; Genetic | 2007 |
Genetic predisposition to environmental factors.
Topics: Drug-Related Side Effects and Adverse Reactions; Environment; Genes, MHC Class II; Genetic Linkage; | 1983 |
5 other studies available for succinylcholine and Genetic Predisposition
| Article | Year |
|---|---|
Malignant hyperthermia susceptibility: utilization of genetic results in an electronic medical record to increase safety.
Topics: Anesthetics, Inhalation; Calcium Channels, L-Type; Decision Support Systems, Clinical; Electronic He | 2020 |
Malignant Hyperthermia and Ryanodine Receptor Type 1 Gene (RyR1) Mutation in a Family in Singapore.
Topics: Adult; Dantrolene; Female; Genetic Predisposition to Disease; Humans; Male; Malignant Hyperthermia; | 2017 |
Malignant hyperthermia-like syndrome and carnitine palmitoyltransferase II deficiency with heterozygous R503C mutation.
Topics: Amino Acid Substitution; Anesthetics, Inhalation; Arginine; Carnitine O-Palmitoyltransferase; Child, | 2009 |
Suspected malignant hyperthermia reactions in New Zealand.
Topics: Adolescent; Adult; Anesthetics, Inhalation; Child; Child, Preschool; Female; Genetic Predisposition | 2002 |
Evaluation of greyhound susceptibility to malignant hyperthermia using halothane-succinylcholine anesthesia and caffeine-halothane muscle contractures.
Topics: Anesthesia, Inhalation; Animals; Caffeine; Disease Susceptibility; Dog Diseases; Dogs; Genetic Predi | 1992 |